VUF 11207 (fumarate) 25 mg | ≥98% Cayman Chemical A CXCR7 agonist More Information Supplier Page × VUF 11207 (fumarate)
VUF 11207 (fumarate) 10 mg | ≥98% Cayman Chemical A CXCR7 agonist More Information Supplier Page × VUF 11207 (fumarate)
VUF 11207 (fumarate) 5 mg | ≥98% Cayman Chemical A CXCR7 agonist More Information Supplier Page × VUF 11207 (fumarate)
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt) 5 mg | ≥95% Cayman Chemical An inositol phosphate More Information Supplier Page × D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt)
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt) 500 µg | ≥95% Cayman Chemical An inositol phosphate More Information Supplier Page × D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt)
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt) 10 mg | ≥95% Cayman Chemical An inositol phosphate More Information Supplier Page × D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt)
Semaglutide (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical A GLP-1R agonist More Information Supplier Page × Semaglutide (trifluoroacetate salt)
Semaglutide (trifluoroacetate salt) 25 mg | ≥95% Cayman Chemical A GLP-1R agonist More Information Supplier Page × Semaglutide (trifluoroacetate salt)
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt) 1 mg | ≥95% Cayman Chemical An inositol phosphate More Information Supplier Page × D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (lithium salt)
Survodutide (trifluoroacetate salt) 5 mg | ≥98% Cayman Chemical A peptide agonist of GCGR and GLP-1R More Information Supplier Page × Survodutide (trifluoroacetate salt)
